Clinical Trial Update: ULTRACET (Tramadol Hydrochloride and Acetaminophen) for the Treatment of Rheumatoid Arthritis Pain. [Phase 4]

View source ↗

Summary

Phase 4 trial update on ULTRACET (tramadol hydrochloride and acetaminophen) for rheumatoid arthritis pain; trial status completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• ULTRACET (tramadol hydrochloride/acetaminophen)

Snippet

Sponsor: Janssen Korea, Ltd., Korea | Conditions: Arthritis, Rheumatoid | Phase 4 | Status: COMPLETED